IL6 and brain inflammatory disease: Thus, the results indicate the neuroprotective effect of chondroitin sulfate as an anti-inflammatory agent by suppressing the NF-kB and decreasing the inflammatory mediators (IL-1β, IL-6, and TNF-alpha) that act as biomarkers of brain inflammation.